- Home
- LYEL vs ARAY Comparison
LYEL vs ARAY Comparison
Compare LYEL & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYEL
- ARAY
- Stock Information
- Founded
- LYEL 2018
- ARAY 1990
- Country
- LYEL United States
- ARAY United States
- Employees
- LYEL N/A
- ARAY N/A
- Industry
- LYEL Biotechnology: Pharmaceutical Preparations
- ARAY Medical/Dental Instruments
- Sector
- LYEL Health Care
- ARAY Health Care
- Exchange
- LYEL Nasdaq
- ARAY Nasdaq
- Market Cap
- LYEL 207.7M
- ARAY 229.3M
- IPO Year
- LYEL 2021
- ARAY 2007
- Fundamental
- Price
- LYEL $8.69
- ARAY $1.24
- Analyst Decision
- LYEL Sell
- ARAY
- Analyst Count
- LYEL 2
- ARAY 0
- Target Price
- LYEL $20.00
- ARAY N/A
- AVG Volume (30 Days)
- LYEL 253.7K
- ARAY 1.1M
- Earning Date
- LYEL 08-06-2025
- ARAY 08-13-2025
- Dividend Yield
- LYEL N/A
- ARAY N/A
- EPS Growth
- LYEL N/A
- ARAY N/A
- EPS
- LYEL N/A
- ARAY 0.01
- Revenue
- LYEL $65,000.00
- ARAY $465,251,000.00
- Revenue This Year
- LYEL N/A
- ARAY $3.87
- Revenue Next Year
- LYEL N/A
- ARAY $0.09
- P/E Ratio
- LYEL N/A
- ARAY $183.07
- Revenue Growth
- LYEL N/A
- ARAY 8.06
- 52 Week Low
- LYEL $7.65
- ARAY $1.14
- 52 Week High
- LYEL $45.42
- ARAY $2.95
- Technical
- Relative Strength Index (RSI)
- LYEL 44.96
- ARAY 32.25
- Support Level
- LYEL $8.96
- ARAY $1.21
- Resistance Level
- LYEL $10.96
- ARAY $1.29
- Average True Range (ATR)
- LYEL 2.14
- ARAY 0.06
- MACD
- LYEL -0.17
- ARAY -0.02
- Stochastic Oscillator
- LYEL 16.91
- ARAY 21.89
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.